Zimmermann, M <br/><br/>
Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist.  [electronic resource] 

 -  Neurosurgery  Jan 1996 
 - 115-20 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0148-396X 
<br/><br/><label>Standard No.: </label>10.1097/00006123-199601000-00028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Basilar Artery--diagnostic imaging<br/>Bosentan<br/>Cerebral Angiography--drug effects<br/>Dogs<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Endothelin Receptor Antagonists<br/>Female<br/>Ischemic Attack, Transient--diagnostic imaging<br/>Male<br/>Receptors, Endothelin--physiology<br/>Subarachnoid Hemorrhage--complications<br/>Sulfonamides--pharmacokinetics<br/>Vascular Resistance--drug effects